DNA Methylation Profiles of MGMT, DAPK1, hMLH1, CDH1, SHP1, and HIC1 in B-Cell Lymphomas
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : This study was designed to examine the prevalence of aberrant promoter methylation in a selected panel of genes potentially involved in lymphoid tumors. Methods : The promoter hypermethylation status of MGMT, DAPK1, hMLH1, CDH1, SHP1, and HIC1 was measured by methylation-specific PCR for 82 cases of B-cell lymphoma. Immunohistochemical staining using MGMT and SHP1 antibodies was conducted on 43 out of 82 cases. Results : The number of MGMT aberrant methylations was lower in diffuse large B-cell lymphoma (DLBCL) than in other malignant lymphomas. The methylation of DAPK1 was frequently detected in follicular lymphoma (FL), marginal zone B-cell lymphoma (MZL) and DLBCL. With one exception, methylation of hMLH1 was not observed in B-cell lymphomas. The methylation frequency of CDH1, and HIC1 was similar in B-cell lymphomas. However, the methylation of SHP1 gene was more frequently observed in cases of FL, DLBCL, and MZL than in chronic lymphocytic lymphoma. MGMT and SHP1 promoter methylation were inversely correlated with the protein expression observed upon immunohistochemical staining. Conclusions : Aberrant promoter methylation of multiple genes occurs with variable frequency throughout the B-cell lymphomas, and methylation of hMLH1 is rarely observed in B-cell lymphomas.
Abstract
Background : This study was designed to examine the prevalence of aberrant promoter methylation in a selected panel of genes potentially involved in lymphoid tumors. Methods : The promoter hypermethylation status of MGMT, DAPK1, hMLH1, CDH1, SHP1, and HIC1 was measured by methylation-specific PCR for 82 cases of B-cell lymphoma. Immunohistochemical staining using MGMT and SHP1 antibodies was conducted on 43 out of 82 cases. Results : The number of MGMT aberrant methylations was lower in diffuse large B-cell lymphoma (DLBCL) than in other malignant lymphomas. The methylation of DAPK1 was frequently detected in follicular lymphoma (FL), marginal zone B-cell lymphoma (MZL) and DLBCL. With one exception, methylation of hMLH1 was not observed in B-cell lymphomas. The methylation frequency of CDH1, and HIC1 was similar in B-cell lymphomas. However, the methylation of SHP1 gene was more frequently observed in cases of FL, DLBCL, and MZL than in chronic lymphocytic lymphoma. MGMT and SHP1 promoter methylation were inversely correlated with the protein expression observed upon immunohistochemical staining. Conclusions : Aberrant promoter methylation of multiple genes occurs with variable frequency throughout the B-cell lymphomas, and methylation of hMLH1 is rarely observed in B-cell lymphomas.
참고문헌 (30)
- Jones PA, "The fundamental role of epigenetic events in cancer", Nat Rev Genet, 3, pp.415~428 (2002)
- Baylin SB, "Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer", Hum Mol Genet, 10, pp.687~692 (2001)
- Costello JF, "Aberrant CpG-island methylation has non-random and tumour-type-specific patterns", Nat Genet, 24, pp.132~138 (2000)
- Esteller M, "A gene hypermethylation profile of human cancer", Cancer Res, 61, pp.3225~3229 (2001)
- Baur AS, "Frequent methylation silencing of p15 (INK4b) (MTS2) and p16 (INK-4a) (MTS1) in B-cell and T-cell lymphomas", Blood, 94, pp.1773~1781 (1999)
- Chim CS, "SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak", STAT pathway, 2004, pp.18, 356~358
- Esteller M, "Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma", J Natl Cancer Inst, 94, pp.26~32 (2002)
- Rossi D, "Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiencyrelated lymphomas", Br J Haematol, 123, pp.475~478 (2003)
- Katzenellenbogen RA, "Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies", Blood, 93, pp.4347~4353 (1999)
- Menigatti M, "Nomal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters", Oncogene, 28, pp.899~909 (2009)
- Cohen O, "DAP-kinase is a Ca2+", calmodulindependent, cytoskeletal-associated protein kinase, with cell deathinducing functions that depend on its catalytic activity, 1997, pp.16, 998~1008
- Kissil JL, "DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene", Oncogene, 15, pp.403~407 (1997)
- Inbal B, "DAP- kinase links the control of apoptosis to metastasis", Nature, 390, pp.180~184 (1997)
- Sanchez-Beato M, "Cell cycle deregulation in B-cell lymphomas", Blood, 101, pp.1220~1235 (2003)
- Siu LL, "Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas", Br J Haematol, 122, pp.70~77 (2003)
- Chu LC, "Epigenetic silencing of multiple genes in primary CNS lymphoma", Int J Cancer, 119, pp.2487~2491 (2006)
- Scarisbrick JJ, "Microsatellite instability is associated with hypermethylation of the hMLH1 gene and reduced gene expression in mycosis fungoides", J Invest Dermatol, 121, pp.894~901 (2003)
- Tang X, "Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer", J Natl Cancer Inst, 92, pp.1511~1516 (2000)
- Ogama Y, "Prevalent hypermethylation of the CDH13 gene promoter in malignant B cell lymphomas", Int J Oncol, 25, pp.685~691 (2004)
- Delibrias CC, "Down regulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes", J Exp Med, 186, pp.1575~1583 (1997)
- Kossev PM, "SHP-1 expression by malignant small B-cell lymphomas reflects the maturation stage of their normal B-cell counterparts", Am J Surg Pathol, 25, pp.949~955 (2001)
- Oka T, "Reduction of hematopoietic cellspecific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas", leukemias: combination analysis with cDNA expression array and tissue microarray, 2001, pp.159, 1495~1505
- Koyama M, "Activated proliferation of Bcell lymphomas", leukemias with the SHP1 gene silencing by aberrant CpG methylation, 2003, pp.83, 1849~1858
- Wales MM, "p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3", Nat Med, 1, pp.570~577 (1995)
- Issa JP, "HIC1 hypermethylation is a late event in hematopoietic neoplasms", Cancer Res, 57, pp.1678~1681 (1997)
- Zhou W, "EMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations", J Korean Med Sci, 24, pp.97~103 (2009)
- Lenz G, "Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia", Ann Hematol, 83, pp.628~633 (2004)
- Park SJ, "Frequent CpG island methylation in serrated adenomas of the colorectum", Am J Pathol, 162, pp.815~822 (2003)
- Oka T, "Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias", lymphomas, 2002, pp.62, 6390~6394
- Ekmekci CG, "Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia", Am J Hematol, 77, pp.233~240 (2004)
